First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment
Authors
Keywords
-
Journal
WORLD JOURNAL OF UROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-28
DOI
10.1007/s00345-022-03959-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma.
- (2021) Siamak Daneshmand et al. JOURNAL OF CLINICAL ONCOLOGY
- Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
- (2021) Silke Gillessen et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
- (2021) Jörg Beyer et al. JOURNAL OF CLINICAL ONCOLOGY
- The PRIMETEST trial: Interim analysis of a phase II trial for primary retroperitoneal lymph node dissection (RPLND) in stage II A/B seminoma patients without adjuvant treatment.
- (2019) Peter Albers et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance
- (2019) Robert J. Hamilton et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma
- (2019) Stefanie Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- (2019) Timothy Gilligan et al. Journal of the National Comprehensive Cancer Network
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Non–risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary
- (2018) Phillip Martin Pierorazio et al. EUROPEAN UROLOGY
- Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in—Time to Start Backing Out
- (2018) Rune A.W. van de Wetering et al. JOURNAL OF CLINICAL ONCOLOGY
- High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience
- (2017) Nabil Adra et al. JOURNAL OF CLINICAL ONCOLOGY
- Surveillance versus adjuvant radiotherapy for patients with high-risk stage I seminoma
- (2016) Mette S. Mortensen et al. CANCER
- Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma
- (2015) Brian Hu et al. Clinical Genitourinary Cancer
- Guidelines on Testicular Cancer: 2015 Update
- (2015) Peter Albers et al. EUROPEAN UROLOGY
- Patterns of Relapse in Patients With Clinical Stage I Testicular Cancer Managed With Active Surveillance
- (2015) Christian Kollmannsberger et al. JOURNAL OF CLINICAL ONCOLOGY
- One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group
- (2014) T. Tandstad et al. ANNALS OF ONCOLOGY
- A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program
- (2014) Mette Saksø Mortensen et al. EUROPEAN UROLOGY
- Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors
- (2012) C. Massard et al. ANNALS OF ONCOLOGY
- Sequential Versus Single High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell Tumors: Long-Term Results of a Prospective Randomized Trial
- (2012) Anja Lorch et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study
- (2011) Jorge Aparicio et al. JOURNAL OF CLINICAL ONCOLOGY
- Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database
- (2011) Anja Lorch et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group
- (2011) Torgrim Tandstad et al. JOURNAL OF CLINICAL ONCOLOGY
- TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis
- (2010) Darren R. Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group
- (2008) Peter Albers et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search